Single-Infusion of Donor Early Apoptotic Cells (ApoCell) As Prophylaxis of Graft-Versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantati

被引：0
|
作者：
Mevorach, Dror [1 ]
Reiner, Inna [1 ]
Or, Reuven [2 ]
机构：
[1] Hadassah Hebrew Univ, Jerusalem, Israel
[2] Hadassah Univ Hosp, IL-91120 Jerusalem, Israel
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4176.4176
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4176
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Single infusion of donor early apoptotic cells (ApoCell) as prophylaxis of graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation
    Mevorach, D.
    Reiner, I.
    Zuckerman, T.
    Shimoni, A.
    Nagler, A.
    Rowe, J.
    Or, R.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S172 - S172
  • [2] Single Infusion of Donor Mononuclear Early Apoptotic Cells as Prophylaxis for Graft-versus-Host Disease in Myeloablative HIA-Matched Allogeneic Bone Marrow Transplantation: A Phase I/IIa Clinical Trial
    Mevorach, Dror
    Zuckerman, Tsila
    Reiner, Inna
    Shimoni, Avichai
    Samuel, Simcha
    Nagler, Arnon
    Rowe, Jacob M.
    Or, Reuven
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (01) : 58 - 65
  • [3] Early Apoptotic Cells (ApoCell) As Prophylaxis of GraftVersus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation Is Safe and Effective: 1 Year Follow-up
    Mevorach, Dror
    Tzila, Zuckerman
    Nagler, Arnon
    Rowe, Jacob M.
    Or, Reuven
    [J]. BLOOD, 2014, 124 (21)
  • [4] EARLY APOPTOTIC CELLS AS PROPHYLAXIS OF GRAFT VERSUS-HOST DISEASE IN. MYELOABLATIVE HLA-MATCHED ALLOGENEIC BONE MARROW TRANSPLANTATION IS SAFE AND EFFECTIVE: 1 YEAR FOLLOW-UP AND BIOMARKER PROFILE
    Mevorach, D.
    Tabib, A.
    [J]. CYTOTHERAPY, 2016, 18 (06) : S23 - S23
  • [5] DONOR ALLOREACTIVITY MAY PREDICT ACUTE GRAFT-VERSUS-HOST DISEASE IN HLA-MATCHED BONE-MARROW TRANSPLANTATION FOR LEUKEMIA IN EARLY REMISSION
    JOHNSEN, HE
    BEATTY, PG
    MICHELSON, E
    HANSEN, JA
    THOMAS, ED
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1992, 48 (05) : 249 - 253
  • [6] Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Rondon, Gabriela
    Al-Atrash, Gheath
    Bashir, Qaiser
    Hosing, Chitra M.
    Kebriaei, Partow
    Khouri, Issa
    Nieto, Yago
    Oran, Betul
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Ramdial, Jeremy
    Srour, Samer A.
    Champlin, Richard E.
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    Alousi, Amin M.
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (10): : 695.e1 - 695.e10
  • [7] TRANSFUSION EFFECT ON GRAFT-VERSUS-HOST DISEASE AND LEUKEMIC RELAPSE IN HLA-MATCHED BONE-MARROW TRANSPLANTATION
    DEGAST, GC
    BEATTY, PG
    AMOS, D
    SULLIVAN, K
    ANDERSON, JE
    THOMAS, ED
    HANSEN, JA
    [J]. TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 2700 - 2700
  • [8] Are the functional assays useful in predicting graft-versus-host disease in HLA-matched sibling bone marrow transplantation?
    Dickinson, A
    Wang, XN
    [J]. TRANSPLANTATION, 2001, 72 (06) : 1168 - 1168
  • [9] Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation
    PG Middleton
    H Cullup
    AM Dickinson
    J Norden
    GH Jackson
    PRA Taylor
    J Cavet
    [J]. Bone Marrow Transplantation, 2002, 30 : 223 - 228
  • [10] Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation
    Middleton, PG
    Cullup, H
    Dickinson, AM
    Norden, J
    Jackson, GH
    Taylor, PRA
    Cavet, J
    [J]. BONE MARROW TRANSPLANTATION, 2002, 30 (04) : 223 - 228
12345